Results 111 to 120 of about 5,397,667 (244)

LIPIcs, Volume 46, OPODIS'15, Complete Volume

open access: yes, 2016
LIPIcs, Volume 46, OPODIS'15, Complete ...
Cachin, Christian   +2 more
core   +1 more source

Equal Rights, Vol. 12, No. 46, December 26, 1925

open access: yes, 1925
National Woman's Party. Equal Rights, Vol. 12, No.46, December 26, 1925. 1 PDF file, 4 scans.National Woman's Party. Equal Rights, Vol. 12, No.46, December 26, 1925. Equal Rights Newsletter (MS-144).
National Woman's Party
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

De La Chapelle Syndrome: A Rare Case of Male Infertility

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2016
A 25-year-old Indian male presented to Endocrine Outpatient Department of PGIMS Rohtak with chief complaints of inability to father a child in spite of 2 years of unprotected sexual intercourse.
Rajesh Rajput   +3 more
doaj  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Semina: Ciênc. Agrár. Londrina, v. 46, n. 6, 2025

open access: yes
Semina: Ciênc. Agrár. Londrina, v. 46, n. 6, 2025Semina: Ciênc. Agrár. Londrina, v. 46, n.
Semina: Ciênc. Agrár. Londrina, v. 46, n. 6, 2025
core  

Σ (…) Ιωάννης (46)

open access: yes, 2009
Description: GreeceDescription: Ionian Islands (?)Στοιχείο: EλλάδαΣτοιχείο: Επτάνησα (;
Σ (…) Ιωάννης (46)   +1 more
core  

Section 46(1) and 46(1AA) of the TPA : the struggle of the small against the large [PDF]

open access: yes, 2009
The purpose of this article is to highlight the conflict in the policy objectives of subs 46(1) and subs 46(1AA) of the Trade Practices Act 1974 (Cth) (TPA).
Corones, Stephen G.
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy